Transarterial, interventional radiological Treatment of hemorrhoidal disease - EMBORRHOID-MUC

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 30 人开始时间: 2020年3月13日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients with symptomatic internal hemorrhoids 2nd / 3rd degree, lack of response to prior therapies (conservative basic treatment, medication, endoscopic procedures, minimally invasive procedures, contraindication to surgery and failed surgical/endoscopic treatment, negative colonoscopic correlation (during the past 24 months), no existing promising alternative endovascular/surgical therapeutic option, platelet count = 50.000 / µl, PTT < 50 s, INR < 1,5, age-adjusted normal serum creatinine or creatinine clearance = 30 ml/min / 1,73 m² for safe application of contrast media.

•feasible surgical or endoscopic treatment, hemorrhoidal disease 1st and 4th degree, fixed prolaps, absent access via superior mesenteric artery (e.g. after hemicolectomy), after rectal resection, after endovascular aortic repair (EVAR), acute diseases like fissures, infections, abscesses etc., anatomic contraindications: stenoses, fistula, vascular occlusions, prior colorectal surgery, colorectal anomalies, allergic reactions to contrast media, severe kidney failure, pregnancy.

发起方

Klinikum der Universität München, Campus Großhadern